D3 vitamin — Competitive Intelligence Brief

D3 vitamin (D3 vitamin) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin D supplement / Secosteroid. Area: Endocrinology / Bone metabolism / Immunology.

marketed Vitamin D supplement / Secosteroid Vitamin D receptor (VDR) Endocrinology / Bone metabolism / Immunology Small molecule

Target snapshot

D3 vitamin (D3 vitamin) — Medical University of Lodz. Vitamin D3 (cholecalciferol) is converted in the body to its active form, calcitriol, which regulates calcium and phosphate homeostasis and modulates immune function.

Comparator set (2 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
D3 vitamin TARGET	D3 vitamin	Medical University of Lodz	marketed	Vitamin D supplement / Secosteroid	Vitamin D receptor (VDR)
Cholecalciferol (vitamin D)	Cholecalciferol (vitamin D)	University of Tromso	marketed	Vitamin D supplement / Secosteroid	Vitamin D receptor (VDR)
Vitamin D3 tablets	Vitamin D3 tablets	Ain Shams University	marketed	Vitamin D supplement / Secosteroid	Vitamin D receptor (VDR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin D supplement / Secosteroid class)

1. Ain Shams University · 1 drug in this class
2. Medical University of Lodz · 1 drug in this class
3. University of Tromso · 1 drug in this class